Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Neurocrine Biosciences Inc (NBIX)

NASDAQ
Currency in USD
128.15
+1.73(+1.36%)
Closed
After Hours
128.16+0.01(+0.01%)

NBIX Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa788.11,045.91,133.51,488.71,887.1
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+74.67%+32.71%+8.38%+31.34%+26.76%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa207.4285.1342.4487604.7
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa580.7760.8791.11,001.71,282.4
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+99.9%+31.01%+3.98%+26.62%+28.02%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa73.68%72.74%69.79%67.29%67.96%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa354.1433.3583.3752.7887.6
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+42.27%+22.37%+34.62%+29.04%+17.92%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa354.1433.3583.3752.7887.6
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa226.6327.5207.8249394.8
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+444.71%+44.53%-36.55%+19.83%+58.55%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa28.75%31.31%18.33%16.73%20.92%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-12.8-20.2-224.152.8
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+14.67%-57.81%-8.91%+118.64%+1,187.8%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-32-32.8-25.8-7.1-4.6
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa19.212.63.811.257.4
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa213.8307.3185.8253.1447.6
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-154.3-182.9-105.3-70-143.9
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa46.5106.7101.4213.9332.1
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+113.3%+129.46%-4.97%+110.95%+55.26%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa5.9%10.2%8.95%14.37%17.6%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa9.5-300.611.859.482.4
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa37407.389.6154.5249.7
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa37407.389.6154.5249.7
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+75.36%+1,000.81%-78%+72.43%+61.62%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa4.69%38.94%7.9%10.38%13.23%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa37407.389.6154.5249.7
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa0.44.370.951.612.56
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+72.68%+983.08%-78.35%+70.27%+58.48%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa0.394.160.921.562.47
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+77.27%+966.67%-77.88%+69.57%+58.33%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa91.693.194.695.897.7
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa95.797.897.998.9101
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa234336.1218.7264.6416.1
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+413.16%+43.63%-34.93%+20.99%+57.26%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa29.69%32.14%19.29%17.77%22.05%
EBIT
aa.aaaa.aaaa.aa